Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizon
Oral squamous cell carcinoma (OSCC) is a major global health concern even with the developments in conventional therapies of cancer. This editorial aims to review the current genetic and molecular data of OSCC treatment with an emphasis on the Programmed cell death protein 1 (PD-1)/ligand PD-L1 path...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-09-01
|
| Series: | Oral Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S277290602400428X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841553693660413952 |
|---|---|
| author | Prathiksha Srikanthan Suresh Malakondaiah Iadalin Ryntathiang Mukesh Kumar Dharmalingam Jothinathan |
| author_facet | Prathiksha Srikanthan Suresh Malakondaiah Iadalin Ryntathiang Mukesh Kumar Dharmalingam Jothinathan |
| author_sort | Prathiksha Srikanthan |
| collection | DOAJ |
| description | Oral squamous cell carcinoma (OSCC) is a major global health concern even with the developments in conventional therapies of cancer. This editorial aims to review the current genetic and molecular data of OSCC treatment with an emphasis on the Programmed cell death protein 1 (PD-1)/ligand PD-L1 pathway and novel biomarkers. Research shows that PD-1/PD-L1 inhibitors have the possibility to be used in OSCC treatment, and they mainly focus on improving immune functions. In this regard, salivary biomarkers provide early detection approaches with high sensitivity, especially chemerin and matrix metalloproteinase (MMP-9). Immune cell dynamics and personalized immunotherapy are important to be understood to achieve better therapeutic results. Some of them are tumor relapse, and the requirement of accurate prognostic indicators and diagnostic tests. Personalized medicine is one of the possibilities of using genetic knowledge in therapy. Some of the important areas for future research include improving the methods of early diagnosis, as well as identifying the possibilities of applying the concept of personalized medicine. Multicentre and cooperative work are essential for further improvement of the treatment of OSCC. Genetic and molecular studies provide a hope for better OSCC treatments and thus better patient outcomes worldwide. |
| format | Article |
| id | doaj-art-b60d5a29c9b1411881a25b8ffef7a30f |
| institution | Kabale University |
| issn | 2772-9060 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Oral Oncology Reports |
| spelling | doaj-art-b60d5a29c9b1411881a25b8ffef7a30f2025-01-09T06:16:49ZengElsevierOral Oncology Reports2772-90602024-09-0111100582Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizonPrathiksha Srikanthan0Suresh Malakondaiah1Iadalin Ryntathiang2Mukesh Kumar Dharmalingam Jothinathan3Department of Industrial Biotechnology, Bharath Institute of Higher Education and Research, Chennai, 600073, Tamil Nadu, IndiaCentre for Material Engineering and Regenerative Medicine, Bharath Institute of Higher Education and Research, Chennai, 600073, Tamil Nadu, IndiaCentre for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, IndiaCorresponding author.; Centre for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, IndiaOral squamous cell carcinoma (OSCC) is a major global health concern even with the developments in conventional therapies of cancer. This editorial aims to review the current genetic and molecular data of OSCC treatment with an emphasis on the Programmed cell death protein 1 (PD-1)/ligand PD-L1 pathway and novel biomarkers. Research shows that PD-1/PD-L1 inhibitors have the possibility to be used in OSCC treatment, and they mainly focus on improving immune functions. In this regard, salivary biomarkers provide early detection approaches with high sensitivity, especially chemerin and matrix metalloproteinase (MMP-9). Immune cell dynamics and personalized immunotherapy are important to be understood to achieve better therapeutic results. Some of them are tumor relapse, and the requirement of accurate prognostic indicators and diagnostic tests. Personalized medicine is one of the possibilities of using genetic knowledge in therapy. Some of the important areas for future research include improving the methods of early diagnosis, as well as identifying the possibilities of applying the concept of personalized medicine. Multicentre and cooperative work are essential for further improvement of the treatment of OSCC. Genetic and molecular studies provide a hope for better OSCC treatments and thus better patient outcomes worldwide.http://www.sciencedirect.com/science/article/pii/S277290602400428XOral squamous cell carcinoma (OSCC)Matrix metalloproteinase-9 (MMP-9)GeneticMolecularSalivary biomarkersImmune cell |
| spellingShingle | Prathiksha Srikanthan Suresh Malakondaiah Iadalin Ryntathiang Mukesh Kumar Dharmalingam Jothinathan Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizon Oral Oncology Reports Oral squamous cell carcinoma (OSCC) Matrix metalloproteinase-9 (MMP-9) Genetic Molecular Salivary biomarkers Immune cell |
| title | Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizon |
| title_full | Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizon |
| title_fullStr | Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizon |
| title_full_unstemmed | Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizon |
| title_short | Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizon |
| title_sort | genetic and molecular insights in oral squamous cell carcinoma therapy advancing the horizon |
| topic | Oral squamous cell carcinoma (OSCC) Matrix metalloproteinase-9 (MMP-9) Genetic Molecular Salivary biomarkers Immune cell |
| url | http://www.sciencedirect.com/science/article/pii/S277290602400428X |
| work_keys_str_mv | AT prathikshasrikanthan geneticandmolecularinsightsinoralsquamouscellcarcinomatherapyadvancingthehorizon AT sureshmalakondaiah geneticandmolecularinsightsinoralsquamouscellcarcinomatherapyadvancingthehorizon AT iadalinryntathiang geneticandmolecularinsightsinoralsquamouscellcarcinomatherapyadvancingthehorizon AT mukeshkumardharmalingamjothinathan geneticandmolecularinsightsinoralsquamouscellcarcinomatherapyadvancingthehorizon |